| Name | Eribulin Mesilate |
| Synonyms | E7389 Halaven E7389 mesylate B1939 mesylate Eribulin Mesilate Eribulin Mesylate ER-086526 mesylate Eribulin mesylate Halaven |
| CAS | 441045-17-6 |
| EINECS | 813-106-4 |
| Molecular Formula | C41H63NO14S |
| Molar Mass | 826.01 |
| Solubility | 10 mM in DMSO |
| Storage Condition | -20℃ |
| Use | Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer. Eribulin mesylate (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 1.211 ml | 6.053 ml | 12.107 ml |
| 5 mM | 0.242 ml | 1.211 ml | 2.421 ml |
| 10 mM | 0.121 ml | 0.605 ml | 1.211 ml |
| 5 mM | 0.024 ml | 0.121 ml | 0.242 ml |